March 04, 2015 2:14 PM ET

Biotechnology

Company Overview of Danube Pharmaceuticals, Inc.

Executive Profile

Leonard A. Levin M.D., Ph.D.

Member of Scientific Advisory Board, Inotek Pharmaceuticals Corporation
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 2 different industries.

See Board Relationships
----

Background

Mr. Leonard A. Levin, M.D., Ph.D. serves as a Professor and Chair of Ophthalmology, McGill University Professor (CHS) of Ophthalmology and Visual Sciences, University of Wisconsin. Mr. Levin is Chair of the Department of Ophthalmology, McGill University, Physician-in-Chief of Ophthalmology at the McGill University Health Centre (MUHC), Adjunct Professor of Ophthalmology at the Université de Montréal, and Professor of Ophthalmology at the University of Wisconsin. Mr. ...

Corporate Headquarters

689 Fifth Avenue
New York, New York 10022

United States

Phone: 646-375-4641
Fax: 646-375-4651

Board Members Memberships

There is no Board Members Memberships data available.

Education

Bachelor's Degree
Harvard University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Danube Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.